Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03079245 · ClinicalTrials.gov registry record · NA
Improving Antimicrobial Prescribing Practices in the Neonatal ICU
A NA study, sponsored by Columbia University.
- Completed
- Registry status
- NA
- Development phase
- 6,184
- Enrollment target
NCT03079245: Completed NA study, sponsored by Columbia University.
NCT03079245 is a NA study that has completed, run by Columbia University. The registered enrollment target is 6,184 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (341% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03079245, a NA study, has completed, sponsored by Columbia University.
- COMPLETED
- Registry status
- NA
- Development phase
- 6,184 participants
- Enrollment target
Study Summary
To determine if 3 randomly assigned bundles of stewardship interventions would reduce overall and inappropriate antimicrobial use in the neonatal intensive care unit (NICU), a pre-post study was performed in 4 NICUs.
Primary Outcome
The indications for initiation of intravenous antimicrobials were categorized as initiation of empiric therapy (antibiotics started prior to culture results), definitive therapy (culture results available prior to initiation of antibiotics), or prophylaxis (e.g., antibiotics for postoperative prophylaxis).
Interventions
- OTHER Clinical Decision Support
- OTHER Education Plus (E+)
- OTHER Prescriber Audit and Feedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,184 participants |
| Start Date | 2009-05-01 |
| Est. Completion | 2012-04-30 |
| Phase | NA |
What the finished NCT03079245 record still lists
NCT03079245 is an interventional study that assigns participants to a tested intervention. Its 6,184 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (341% higher).
The record links to 0 conditions, and to 3 interventions - of which Clinical Decision Support is the first listed.
NCT03079245 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03079245 about?
NCT03079245 is a clinical study titled "Improving Antimicrobial Prescribing Practices in the Neonatal ICU". To determine if 3 randomly assigned bundles of stewardship interventions would reduce overall and inappropriate antimicrobial use in the neonatal intensive care unit (NICU), a pre-post study was performed in 4 NICUs.
What is the current status of trial NCT03079245?
This trial is currently completed. It is a NA study. The enrollment target is 6,184 participants. The study started on 2009-05-01. Estimated completion is 2012-04-30.
What interventions are being tested in trial NCT03079245?
The interventions under investigation include: Clinical Decision Support (OTHER), Education Plus (E+) (OTHER), Prescriber Audit and Feedback (OTHER).
Who is sponsoring clinical trial NCT03079245?
This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03079245's enrollment target sits among peer trials
6,184 22nd of 2000 higher than 1,979 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07049861 · 6,200 participants · NA
Advancing Biopsychosocial Care Training Initiative
- NCT04774159 · 6,150 participants · Phase 3
Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
- NCT06304168 · 6,150 participants
Validation of DNA Methylation Markers for Universal and Site-specific Guided Cancer Detection, VANGUARD Study
- NCT03960099 · 6,250 participants · NA
Pictographs for Preventing Wrong-Patient Errors in NICUs
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI